Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uma Borate

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Translational Behavioral Medicine|February 2, 2018
Improving shared decision-making in chronic lymphocytic leukemia through multidisciplinary educationGabrielle B Rocque, Courtney P Williams, Karina I Halilova, et al.
Breast Cancer Research : BCR|November 7, 2024
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancerJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
The Oncologist|May 25, 2026
Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 studyJean-Jacques Kiladjian, Uma Borate, Elisabetta Abruzzese, et al.
Blood|December 9, 2024
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromesJacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike, et al.
Leukemia & Lymphoma|July 18, 2012
Examining racial differences in diffuse large B-cell lymphoma presentation and survivalChristopher R Flowers, Pareen J Shenoy, Uma Borate, et al.
American Journal of Hematology|October 30, 2022
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromesAmer M Zeidan, Uma Borate, Daniel A Pollyea, et al.
Journal of Translational Medicine|December 16, 2018
Implementing a comprehensive translational oncology platform: from molecular testing to actionabilityZahi I Mitri, Swapnil Parmar, Brett Johnson, et al.
Therapeutic Innovation & Regulatory Science|May 17, 2021
Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master TrialLen Rosenberg, Hugh Levaux, Ross L Levine, et al.
Journal of Hematology & Oncology|June 24, 2021
A precision medicine classification for treatment of acute myeloid leukemia in older patientsAlice S Mims, Jessica Kohlschmidt, Uma Borate, et al.
Blood Advances|October 20, 2017
US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALLFarhad Ravandi, Megan Othus, Susan M O'Brien, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Translational Behavioral Medicine|February 2, 2018
Improving shared decision-making in chronic lymphocytic leukemia through multidisciplinary educationGabrielle B Rocque, Courtney P Williams, Karina I Halilova, et al.
Breast Cancer Research : BCR|November 7, 2024
The role of heparan sulfate in enhancing the chemotherapeutic response in triple-negative breast cancerJasmine M Manouchehri, Jharna Datta, Lynn M Marcho, et al.
The Oncologist|May 25, 2026
Add-on parsaclisib for patients with myelofibrosis and suboptimal response to ruxolitinib: a randomized phase 3 studyJean-Jacques Kiladjian, Uma Borate, Elisabetta Abruzzese, et al.
Blood|December 9, 2024
Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromesJacqueline S Garcia, Uwe Platzbecker, Olatoyosi Odenike, et al.
Leukemia & Lymphoma|July 18, 2012
Examining racial differences in diffuse large B-cell lymphoma presentation and survivalChristopher R Flowers, Pareen J Shenoy, Uma Borate, et al.
American Journal of Hematology|October 30, 2022
A phase 1b study of venetoclax and azacitidine combination in patients with relapsed or refractory myelodysplastic syndromesAmer M Zeidan, Uma Borate, Daniel A Pollyea, et al.
Journal of Translational Medicine|December 16, 2018
Implementing a comprehensive translational oncology platform: from molecular testing to actionabilityZahi I Mitri, Swapnil Parmar, Brett Johnson, et al.
Therapeutic Innovation & Regulatory Science|May 17, 2021
Streamlined Operational Approaches and Use of e-Technologies in Clinical Trials: Beat Acute Myeloid Leukemia Master TrialLen Rosenberg, Hugh Levaux, Ross L Levine, et al.
Journal of Hematology & Oncology|June 24, 2021
A precision medicine classification for treatment of acute myeloid leukemia in older patientsAlice S Mims, Jessica Kohlschmidt, Uma Borate, et al.
Blood Advances|October 20, 2017
US Intergroup Study of Chemotherapy Plus Dasatinib and Allogeneic Stem Cell Transplant in Philadelphia Chromosome Positive ALLFarhad Ravandi, Megan Othus, Susan M O'Brien, et al.
Pageof 6